Search
Document
Interdisciplinary Vasculopathy Care
The UCSF Vasculopathy Clinic provides comprehensive, interdisciplinary care for patients with moyamoya disease, atherosclerosis and other conditions that cause intracranial vasculopathy.
News
Signs of Multiple Sclerosis Show Up in Blood Years Before Symptoms
In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
News
Targeted Therapy, Treatment Disparity Featured at Cancer Meeting
Leading cancer researchers from UC San Francisco presented talks about advances in targeted therapy, cancer genomics, eliminating treatment disparities and other cancer research topics at this year’s annual meeting of the American Association for Cancer Research (AACR) conference...
News
Can a New Drug Candidate Cure Pancreatic Cancer?
UC San Francisco researchers have designed a candidate drug that could help make pancreatic cancer, which is almost always fatal, a treatable, perhaps even curable, condition.
News
New Predictive MS Blood Test May Help Prevent Disability Worsening
Patients with multiple sclerosis (MS) whose blood tests reveal elevated neurofilament light chain (NfL), a biomarker of nerve damage, are at risk of experiencing disability worsening one to two years later, according to a new study spearheaded by UCSF researchers.
News
Novel Tricuspid Valve Procedure Improves Patients' Quality of Life and Health Status
UC San Francisco interventional cardiologists and interventional echocardiographers recently performed the health system’s first commercial transcatheter tricuspid valve replacement procedure using the Edwards Evoque system.
News
Can AI Predict Serious Adverse Events From IBD Therapies?
In a groundbreaking study, UCSF researchers used a new clinical large language model (LLM) to identify serious adverse events (SAEs) occurring in patients treated with immunosuppressants to manage inflammatory bowel disease (IBD).
News
Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?
Approximately 12,000 Americans are diagnosed each year with glioblastoma. Patients survive on average for just 15 months after their diagnosis, and new treatments are urgently needed.
News
New Alzheimer’s Trial to Combine Anti-Amyloid and Anti-Tau Therapies to Arrest Disease Progression
A new study will combine an Alzheimer’s medication that slows disease progression in some patients with two drugs that target disease-driving proteins to see whether their effects can be amplified.
News
How a Cardiogenic Shock Rapid Transfer Protocol Enables Lifesaving Patient Care: Case Study
UCSF has a rapid transfer protocol in place, which includes immediate access to a critical care cardiologist, expedited triage and a dedicated unit for patients transferring in for emergent care.
News
First-of-its-Kind Amputation Prevention Center Offers Hope for the Toughest Cases
Rogelio Jacinto had five days until doctors planned to amputate his leg. It was an emotionally wrenching end to five months of unsuccessful visits to specialists to treat a diabetic foot ulcer.
News
150 Milestone: Robotic Procedure Changes Prostate Cancer Care
UCSF Health has performed 150 robotic focal high-intensity focused ultrasound (HIFU) procedures for patients living with prostate cancer, becoming the first on the West Coast and the first UC Health System to reach that milestone.
News
Physician Survey Shows Lack of Understanding of the FDA’s Approval Process
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than they are, according to a national survey of physicians conducted by researchers at UC San Francisco (UCSF).
News
Study Finds Paxlovid Treatment Does Not Reduce Risk of Long COVID
A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their first COVID-19 infection.
News
Adult Acquired Buried Penis: Improving Patient Outcomes
Adult-acquired buried penis (AABP) is a condition in which excess or abnormal surrounding soft tissue covers the penis, resulting in sexual and urinary dysfunction. While it’s associated with obesity, AABP does not typically subside with weight loss.
News
How a Cutting-Edge Genetic Test Helps Ill Newborns, Pregnant Moms
UCSF is first in Northern California to offer rapid test in-house for faster and more accurate diagnosis of rare genetic conditions.
News
Is Regenerative Medicine the Next Generation of Infertility Treatment?
Failed or canceled frozen embryo transfer (FET) cycles often occur in patients with thin endometrial linings. Existing treatments to increase lining thickness, such as hormone therapy, are not always effective, leaving some patients with little hope of a successful pregnancy.
News
Why Has Progress in the Treatment of Alzheimer’s Disease Taken 30 Years?
UCSF expert examines the past and future of clinical trials for Alzheimer’s Disease.
News
Long-term Marijuana Smoking Can Impair Blood Vessel Function
It’s been known for many years that people who smoke tobacco have poor blood vessel function. Now, a team of researchers at UC San Francisco has shown for the first that people who smoke marijuana have the same problem.
News
Tiny, Focused Shocks Help Many Patients Overcome Heart Arrhythmia
Pulsed field ablation uses a series of tiny electrical pulses to destroy the tissue causing the arrhythmia. The procedure takes an hour or less, compared to three or four hours for conventional treatment.
News
Improving Clinical Outcomes for Venous Thromboembolism
Venous thromboembolism (VTE) is serious condition that begins with a blood clot in a vein – often in the lower leg – that makes its way to the lungs, causing a pulmonary embolism with potentially fatal consequences.
News
Are New Therapies on the Horizon for Painful Skin Condition?
UCSF Health leads multi-center study of chronic inflammation of the skin that affects women and people of color disproportionately.
News
Radioligand Therapy Plus Pembrolizumab May Benefit Patients with Advanced Prostate Cancer
Immune checkpoint inhibitors have demonstrated limited efficacy in treating prostate cancer. Efforts to improve outcomes with combination therapies have mostly failed to demonstrate improvements compared to other types of cancer.
News
What Matters Most to Patients Dealing With Stress Urinary Incontinence?
Many patients experience stress urinary incontinence (SUI) following surgical treatment for prostate cancer. To understand the impact of SUI on quality of life, a team of UCSF researchers interviewed and surveyed patients and published a series of studies.
